On 2 May 2013, the European Scientific Working group on Influenza (ESWI) held its third influenza summit at the Institute of European Studies at the Free University of Brussels. ESWI brought together more than 90 representatives of organizations of healthcare providers, senior citizens, at-risk patients and public health authorities for a day of tailored lectures, Q&A sessions and networking. Since recent studies, surveys and reviews have shed new light on some of the most intriguing influenza issues, the Summit faculty translated the newest scientific data into practice. The first part of the Summit programme focused on the current flu status in Europe, paying special attention to the protection of pregnant women and the elderly as well as to the issues of vaccine safety and effectiveness. The programme continued to highlight future challenges and evolutions like novel antiviral drugs against influenza, improved flu vaccines and the prospect of a universal flu vaccine. The annual ESWI flu summits are the pinnacles of ESWI's efforts to bridge the gap between science and society. ESWI's members are convinced that the fight against influenza can only be won when all parties are well informed and ready to work together.

dx.doi.org/10.1016/j.vaccine.2013.10.078, hdl.handle.net/1765/59216
Vaccine
Department of Virology

McElhaney, J.E, & Osterhaus, A.D.M.E. (2013). Third European Influenza Summit. Organized by the European Scientific Working group on Influenza (ESWI). In Vaccine (Vol. 31, pp. 6161–6167). doi:10.1016/j.vaccine.2013.10.078